Jennifer Devine, J.D., L.L.M.

Jennifer Devine, J.D.
SVP Documentary Standards & Compendial Policy

In her role as Senior Vice President, Documentary Standards and Compendial Policy at USP, Jennifer leads activities related to the development of documentary standards for small molecules, excipients, foods, dietary supplements, and herbal medicines. Jennifer is responsible for Compendial Policy and Compendial Operations which supports USP’s scientific expert volunteers. She also leads the development and execution of the strategy for development of quality standards and helps ensure standards evolve so as to continuously maximize USP’s public health impact.

Prior to her current role, Jennifer was Vice President of Global Legal Affairs at USP

Jennifer serves as executive sponsor of the affinity group, LIVE!, Latinx Integration working with Values and advocating for Excellence.

Career Highlights:

  • U.S. Food and Drug Administration: Associate Commissioner and Deputy Director, Global Regulatory Operations and Policy
  • U.S. Food and Drug Administration: Deputy Director and Associate Director, CDER Office of Compliance


  • Georgetown University Law Center, Master of Laws (LL.M.), International Law
  • Delaware Law School, Juris Doctorate (J.D.)
  • University of Maryland, College Park, B.A.

Awards, Recognition, Admissions: 

  • Bar Admissions: State of Maryland, Washington, D.C., and Commonwealth of Pennsylvania
  • Executive Board Member, Vice President: Food and Drug Administration Alumni Association

Professional Achievements:

  • Re-conceptualizing how USP develops standards and engages with stakeholders.
  • Development of FDA’s strategy for confronting globalization and import safety through the Pathway to Global Product Safety and Quality report.
  • Negotiated with Congress and industry to obtain stronger drug supply chain authorities codified in the FDA Safety and Innovation Act of 2012.
  • Directed and supported key public health programs at FDA related to drugs, unapproved drug initiative, over-the counter drugs, compounding and the integrity of the supply chain.
  • Enactment of the Patient Safety Act and the Patient Safety Organization.

linkedin profile